Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 66

Results For "drug"

4441 News Found

India’s pharma market to hit US$ 130 billion, exports US$ 80 billion by 2030: ASSOCHAM
News | June 12, 2026

India’s pharma market to hit US$ 130 billion, exports US$ 80 billion by 2030: ASSOCHAM

Knowledge paper highlights biosimilars, biologics, AI-driven drug discovery and regulatory excellence as key growth drivers for the next phase of India's pharma expansion


Govt approval to KIHT as CRO expands India’s innovation capabilities
Clinical Trials | June 12, 2026

Govt approval to KIHT as CRO expands India’s innovation capabilities

KIHT can now conduct clinical research for drugs and medical devices, strengthening evidence generation and healthcare innovation


Biopharma SHAKTI envisages launch of 100 biologics by 2047:  Anupriya Patel
Policy | June 12, 2026

Biopharma SHAKTI envisages launch of 100 biologics by 2047: Anupriya Patel

The union minister spoke at the 2nd Pharma Summit & Awards 2026 organised by ASSOCHAM in New Delhi


Industry, regulators and quality experts discuss implementation of Indian Pharmacopoeia 2026
Policy | June 12, 2026

Industry, regulators and quality experts discuss implementation of Indian Pharmacopoeia 2026

Indian Pharmacopoeia Commission hosts scientific conclave to brainstorm on strengthening pharmaceutical quality and compliance


Parexel to showcase AI, real-world evidence and patient-centric innovations at DIA 2026
Clinical Trials | June 12, 2026

Parexel to showcase AI, real-world evidence and patient-centric innovations at DIA 2026

Company experts to participate in eight sessions covering AI-powered clinical development, regulatory innovation, oncology research, and patient engagement


Ipca Labs, BRL to co-develop next-gen biologics for cancer and autoimmune diseases
News | June 12, 2026

Ipca Labs, BRL to co-develop next-gen biologics for cancer and autoimmune diseases

The collaboration aims to develop differentiated biologics that offer greater convenience and accessibility for patients


Dr. Mahesh N. Padamwar joins MSN Laboratories as Senior General Manager
People | June 11, 2026

Dr. Mahesh N. Padamwar joins MSN Laboratories as Senior General Manager

Pharmaceutical R&D veteran brings over 20 years of expertise in formulation development, ANDA filings, and regulated-market product innovation to strengthen MSN Laboratories’ global growth ambitions


ASMS explores strategic research collaboration with Mediciti Institute
News | June 11, 2026

ASMS explores strategic research collaboration with Mediciti Institute

Partnership discussions focus on clinical validation, real-world evidence generation and adoption of indigenous diagnostic technologies across healthcare settings


Bayer’s asundexian moves into EU regulatory review as stroke prevention race intensifies
News | June 11, 2026

Bayer’s asundexian moves into EU regulatory review as stroke prevention race intensifies

The validation confirms the submission is complete, clearing the way for the EMA’s centralized review process to formally evaluate the therapy


Alembic Pharma receives USFDA tentative approval for generic Larotrectinib capsules
Drug Approval | June 11, 2026

Alembic Pharma receives USFDA tentative approval for generic Larotrectinib capsules

Company may qualify for 180-day generic exclusivity as sole first applicant for Bayer’s Vitrakvi capsules in the U.S.